Navigation Links
Transcept Pharmaceuticals to Present at Newsmakers in the Biotech Industry Conference
Date:10/18/2010

ve disorder (OCD) who have not adequately responded to treatment with SSRIs.  Transcept plans to begin a Phase 2 study of TO-2061 in 2011.  For further information, please visit the Transcept website at: www.transcept.com.

Forward Looking Statements This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release are forward-looking statements. An example of such a statement is our plan to begin a Phase 2, double-blind, placebo-controlled study of TO-2061 in 2011. Transcept may not actually carryout this plan. Various important factors could cause actual events to differ materially from the forward-looking statements that Transcept makes, include the outcomes from planned Phase 1 studies of TO-2061 and discussions with the FDA about our plan to move forward with the Phase 2 study; dependence on third parties to manufacture TO-2061 and carry-out the planned study; our success in efforts to seek approval for Intermezzo®, our lead product candidate, and the business of Transcept generally. These and other risks are described in greater detail in the "Risk Factors" section of Transcept periodic reports filed with the SEC. Forward-looking statements do not reflect the potential impact of any future in-licensing, collaborations, acquisitions, mergers, dispositions, joint ventures, or investments Transcept may enter into or make. Transcept does not assume any obligation to update any forward-looking statements, except as required by law. Contact:Transcept Pharmaceuticals, Inc.Greg MannDirector, Corporate Communications(510) 215-3567gmann@transcept.com
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Transcept Pharmaceuticals to Present at BIO Investor Forum
2. Transcept Pharmaceuticals to Present at UBS Global Life Sciences Conference
3. Transcept Pharmaceuticals to Present at Rodman & Renshaw and Stifel Nicolaus Investor Conferences in September 2010
4. Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R)
5. Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter
6. Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Transcept Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference on November 17
8. Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12
9. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
10. Transcept Pharmaceuticals to Report First Quarter 2009 Results
11. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015  Hill-Rom Holdings, Inc. (NYSE: ... Enxing Seng has been elected to its Board ... in Residence for Covidien, as well as President of ... of Peripheral Vascular from 2010 to 2012. ... $2.6B acquisition of ev3 Incorporated, where she was a ...
(Date:3/4/2015)... -- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ), a ... Insulin Pumps, today announced the closing of its previously announced ... a price to the public of $11.50 per share, which ... option to purchase up to an additional 787,500 shares. All ... BofA Merrill Lynch and Piper Jaffray ...
(Date:3/4/2015)... OAKS, Calif. , March 4, 2015 ... Board of Directors today declared a $0.79 per share ... will be paid on June 5, 2015, to all ... on May 14, 2015.  About Amgen ... for patients suffering from serious illnesses by discovering, developing, ...
Breaking Medicine Technology:Hill-Rom Elects Stacy Enxing Seng to its Board of Directors 2Tandem Diabetes Care Announces Closing of Underwritten Public Offering of Common Stock 2Amgen Announces 2015 Second Quarter Dividend 2Amgen Announces 2015 Second Quarter Dividend 3
... Cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), ... proprietary product candidates principally for use in the hospital ... corporate overview at the following investment conferences in February: ... Date:   , Tuesday, February 15, 2011 ...
... Feb. 8, 2011 Attendees at the 2011 ... Forum today heard Prime Therapeutics, President and CEO ... pharmaceutical companies and pharmacy benefit managers as health ... greater number of generics enter the market and ...
Cached Medicine Technology:Prime Therapeutics President and CEO Eric Elliott Presents Keynote Address at 2011 PCMA Managed Markets Educational Forum 2
(Date:3/5/2015)... March 05, 2015 Lakeview Regional ... support of the annual American Heart Association’s Heart Walk ... Kolman, Lakeview Regional Chief Executive Officer, is serving as ... Saturday, March 21, 2015 at Fontainebleau State Park beginning ... Regional has 20 individual teams participating in this year’s ...
(Date:3/5/2015)... The pleasing melodies of live bluegrass music will ... bicycle and hand cycle ride as they arrive in Frederick, ... String Band will present a free concert for riders ... Pentagon in Arlington, Virginia. , “We are thrilled and honored ... have sacrificed so much. We love being to give back ...
(Date:3/5/2015)... 2015 In recognition of its ongoing ... Soho Flordis International (SFI) has been honored by the ... global natural medicine company committed to identifying and developing ... safety, and effectiveness. For these efforts the non-profit ABC ... Investment in Phytomedicinal Research Award. , Phytomedicinal research ...
(Date:3/5/2015)... New Brunswick (PRWEB) March 05, 2015 ... help validate product innovations as the company prepares to ... will be comprised of individuals in the Life Sciences ... working with our clients,” said Elandas CEO Ryan Roberts. ... as a successful organization through our collaborative efforts. As ...
(Date:3/4/2015)... Imagine No Malaria’s 2014 World Malaria Day campaign has been ... honor given to nonprofit causes that make a difference. The ... (NTC15) in Austin, Texas. The Rev. Bobbi Kaye Jones, ... on hand for the presentation; she is a member of ... Malaria was one of five finalists selected by Care2, a ...
Breaking Medicine News(10 mins):Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 2Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 3Health News:Flower Hill String Band to Welcome Face of America with Bluegrass Music 2Health News:Flower Hill String Band to Welcome Face of America with Bluegrass Music 3Health News:SFI Receives Prestigious ABC’s Tyler Award Given For Global Research Effort 2Health News:SFI Receives Prestigious ABC’s Tyler Award Given For Global Research Effort 3Health News:Elandas Creates Advisory Board to Help Guide Innovation 2Health News:Imagine No Malaria Receives Care2 Innovator Award 2Health News:Imagine No Malaria Receives Care2 Innovator Award 3
... ... current overview and future projections of the US hospital information technology market , ... Chicago, IL (Vocus) June 2, 2009 -- ... electronic medical record, HIMSS Analytics cuts through the information clutter to clarify which ...
... 2 Darwin National,Assurance Company, a member company of ... AWH ), today announced that Kim Lloyd, Vice President,Healthcare ... at the American Hospital Association (AHA) Solutions Roundtable in,Chicago ... "Market, Claims,and Healthcare Risk Management Update - Measuring Your ...
... solution - Premerus(SM) Diagnostic Accuracy - at AHIP; demonstrates key ... , , FRANKLIN, Tenn., June 2 ... of medical cost management services, will highlight its groundbreaking solution ... America,s Health Insurance Plans (AHIP) Institute 2009. An industry first, ...
... 28, 2009Scientists at Columbia University,s Mailman School of ... Communicable Diseases of National Health Laboratory Service (NICD-NHLS), ... and Roche,s 454 Life Sciences Corporation have discovered ... hemorrhagic fever outbreak in Zambia and South Africa ...
... HARRISBURG, Pa., June 2 Governor Edward G. ... for the Lottery-funded PACENET prescription drug benefit for older Pennsylvanians, ... or no drug coverage now. , , "As ... economic times, providing comprehensive prescription medication coverage is more important ...
... top priority for PA Professional Fire Fighters Association through ... , HARRISBURG, Pa., June 2 The Pennsylvania ... will become the first Fire Fighter State Association to ... This program is part of its long standing commitment ...
Cached Medicine News:Health News:Understand ARRA Spending Allocations with HIMSS Analytics™ Market Intelligence 2Health News:Understand ARRA Spending Allocations with HIMSS Analytics™ Market Intelligence 3Health News:Darwin's Kim Lloyd to Speak on Panel at American Hospital Association Solutions Roundtable, June 3, 2009 2Health News:Darwin's Kim Lloyd to Speak on Panel at American Hospital Association Solutions Roundtable, June 3, 2009 3Health News:MedSolutions: Accurate Diagnosis Is Critical to Reducing Healthcare Costs 2Health News:MedSolutions: Accurate Diagnosis Is Critical to Reducing Healthcare Costs 3Health News:MedSolutions: Accurate Diagnosis Is Critical to Reducing Healthcare Costs 4Health News:New arenavirus discovered as cause of hemorrhagic fever outbreak in South Africa and Zambia 2Health News:New arenavirus discovered as cause of hemorrhagic fever outbreak in South Africa and Zambia 3Health News:Governor Rendell Proposes Offering Prescription Help to 30,000 More Older Adults as Part of Plan to Save $60 Million 2Health News:PA Professional Fire Fighters Association is First State Association in Nation to Offer Smoking Cessation Program 2Health News:PA Professional Fire Fighters Association is First State Association in Nation to Offer Smoking Cessation Program 3Health News:PA Professional Fire Fighters Association is First State Association in Nation to Offer Smoking Cessation Program 4
The GelAir™ dryer is a component of the GelAir drying system. Supplied as a 230 V, 50 Hz gel drying oven....
... The PRO6000 power supply is ... power supply product offering. It ... and genomic electrophoresis. This product ... proteomic applications such as microAmp ...
... Operating as a constant voltage power supply, the ... knob and hilo range switch control the output, ... to 250 volts. One, two-position switch toggles the ... output current. The 105 is equipped with an ...
... The 250-90 low voltage electrophoresis power supply ... 500 milliamps and 125 watts. This product operates ... continuously variable output. The 250-90 automatically crosses over ... when a preset limit is reached. ...
Medicine Products: